Rushani Cameron | Medical Hypotheses | Best Researcher Award

Best Researcher Award

Rushani Cameron
NYU Langone Health

Rushani Cameron
Affiliation NYU Langone Health
Country Thailand
Scopus ID 60539313500
Documents 2
Subject Area Medical Hypotheses
Event International Research Hypothesis Excellence Award
ORCID 0009-0003-0166-1505

Rushani Cameron of NYU Langone Health has demonstrated academic participation through published research outputs and professional involvement in hypothesis-driven medical investigations. The recognition is associated with the International Research Hypothesis Excellence Award program, which acknowledges researchers contributing to scientific discussion, innovation, and evidence-based inquiry.[1]

Abstract

This article presents an academic overview of Rushani Cameron and the scholarly profile associated with research activities in Medical Hypotheses. The profile reflects participation in scientific inquiry, publication efforts, and interdisciplinary engagement within healthcare-related research domains. Recognition through the Best Researcher Award emphasizes academic commitment and contribution to research excellence.[1]

Keywords

Medical Hypotheses, Clinical Research, Scientific Inquiry, Healthcare Innovation, Research Excellence, Academic Contributions, Evidence-Based Medicine, Medical Investigation.

Introduction

Medical hypothesis research serves as a foundation for generating innovative ideas that may lead to future experimental validation and clinical advancement. Researchers working within this domain contribute to scientific progress by identifying emerging concepts, evaluating theoretical frameworks, and encouraging interdisciplinary discussion. Rushani Cameron’s academic activities align with these objectives through engagement in scholarly publication and research dissemination.[1]

Research Profile

Affiliated with NYU Langone Health, Rushani Cameron maintains an academic profile indexed through Scopus and ORCID platforms. The available publication record reflects participation in scholarly communication and scientific reporting relevant to healthcare and medical hypothesis development. Such profiles provide visibility, transparency, and accessibility within the global research community.[1][2]

Research Contributions

Research contributions within the Medical Hypotheses field frequently involve conceptual exploration, theoretical assessment, and interdisciplinary integration. Through published scholarly work, researchers contribute to scientific dialogue by presenting new perspectives and encouraging further investigation. These activities support the advancement of knowledge and provide foundations for future empirical studies.[3]

Publications

  • Indexed scholarly publications available through Scopus author records.
  • Research outputs associated with healthcare and medical hypothesis discussions.
  • Academic publications contributing to scientific communication and evidence-based discourse.

Research Impact

The impact of hypothesis-oriented research extends beyond immediate findings by stimulating discussion, generating future research directions, and supporting innovation in healthcare sciences. Academic visibility through recognized indexing systems enhances dissemination and facilitates collaboration among researchers, clinicians, and institutions.[1]

Award Suitability

Rushani Cameron’s scholarly engagement, publication activity, and participation in scientific communication align with the objectives of the Best Researcher Award. Recognition through the International Research Hypothesis Excellence Award reflects commitment to advancing academic knowledge and fostering intellectual exchange within the Medical Hypotheses discipline.[4]

Conclusion

The academic profile of Rushani Cameron demonstrates participation in research activities relevant to Medical Hypotheses and healthcare innovation. Through scholarly publication, professional visibility, and engagement with recognized research platforms, the profile reflects ongoing contributions to scientific inquiry and knowledge development within the broader medical research community.

References

  1. Elsevier. (n.d.). Scopus author details: Rushani Cameron, Author ID 60539313500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=60539313500
  2. ORCID. (n.d.). ORCID Profile Record.
    https://orcid.org/0009-0003-0166-1505
  3. Preoperative Intra-Articular Corticosteroid Injection Is Not Associated with Inferior Reoperation or Patient-Reported Outcomes Following Chondrocyte Implantation.
    https://www.mdpi.com/2673-4095/7/1/40
  4. International Research Hypothesis Excellence Award. (n.d.). Award Program Information.
    https://researchhypothesis.com/

Ahmed A. Rawwash | Medical Hypotheses | Medical Hypothesis Award

Medical Hypothesis Award

Ahmed A. Rawwash
Researcher at Al-Azhar University, Faculty of Science

Ahmed A. Rawwash
Affiliation Al-Azhar University, Faculty of Science
Country Egypt
Scopus ID 58724354600
Documents 2
Citations 1
h-index 1
Subject Area Medical Hypotheses
Event International Research Hypothesis Excellence Award
ORCID 0009-0009-8291-2284

Ahmed A. Rawwash, a researcher affiliated with Al-Azhar University, Faculty of Science, Egypt. The profile highlights scholarly activity, research metrics, publication visibility, and the relevance of the researcher’s work to the field of medical hypotheses and interdisciplinary scientific inquiry. Available academic indicators, including citation data, publication records, and researcher identifiers, provide a foundation for evaluating research contributions and award suitability within the context of scientific innovation and hypothesis-driven investigation.[1]

Abstract

Ahmed A. Rawwash is an emerging researcher whose scholarly profile reflects engagement with scientific research and hypothesis-oriented investigation. Academic records indicate published work indexed through international research databases and supported by persistent researcher identifiers. Such profiles contribute to the development of evidence-based scientific discourse and the advancement of innovative conceptual frameworks in medicine and related scientific domains.[1][2]

Keywords

  • Medical Hypotheses
  • Scientific Research
  • Research Innovation
  • Academic Recognition
  • Interdisciplinary Science
  • Research Excellence
  • Scholarly Publications
  • Scientific Impact

Introduction

Hypothesis-driven research plays an important role in scientific progress by encouraging the exploration of novel ideas, mechanisms, and theoretical perspectives. Researchers who contribute to this process help expand scientific understanding and stimulate further empirical investigation. The Medical Hypothesis Award recognizes scholarly engagement with innovative thinking, conceptual development, and the advancement of scientific knowledge through structured academic inquiry.[4]

Research Profile

Ahmed A. Rawwash is affiliated with Al-Azhar University, Faculty of Science, one of Egypt’s established academic institutions. Available bibliometric indicators show indexed publications, citation activity, and an h-index reflecting measurable scholarly engagement. Research visibility is further strengthened through internationally recognized researcher identification systems including ORCID and Scopus Author ID.[1][2]

Research Contributions

The research contributions associated with Ahmed A. Rawwash demonstrate participation in scholarly communication through peer-reviewed outputs and indexed research dissemination. Such contributions support the broader scientific ecosystem by generating hypotheses, evaluating theoretical concepts, and contributing to the accumulation of scientific knowledge. The presence of indexed publications indicates engagement with recognized academic publishing standards and international visibility.[1]

Publications

According to indexed author records, Ahmed A. Rawwash has published scholarly works that contribute to his academic profile. Publication activity remains an important indicator of research engagement, visibility, and participation in the international scientific community.[1]

Research Impact

Research impact may be assessed through a combination of publication output, citation activity, scholarly visibility, and engagement with the broader scientific community. Available indicators for Ahmed A. Rawwash include two indexed documents, one citation, and an h-index of one. While bibliometric measures represent only one dimension of scientific achievement, they provide useful evidence of research dissemination and scholarly recognition.[1]

Award Suitability

Ahmed A. Rawwash demonstrates characteristics relevant to consideration for the International Research Hypothesis Excellence Award. These include participation in hypothesis-driven research, publication within indexed academic environments, maintenance of internationally recognized researcher identifiers, and engagement with scientific inquiry. Such attributes align with common evaluation criteria used by academic recognition programs that emphasize originality, scientific relevance, and contribution to scholarly advancement.[1][4]

Conclusion

Ahmed A. Rawwash represents an emerging academic researcher whose profile reflects active participation in scholarly publishing and scientific communication. Through indexed publications, citation activity, and recognized researcher identifiers, the available evidence indicates meaningful engagement with the scientific community. Continued research activity and hypothesis development may further strengthen future scholarly impact and recognition within relevant scientific disciplines.[1][2]

References

  1. Elsevier. (n.d.). Scopus author details: Ahmed A. Rawwash, Author ID 58724354600. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58724354600
  2. ORCID. (n.d.). Ahmed A. Rawwash ORCID record.
    https://orcid.org/0009-0009-8291-2284
  3. Google Scholar. (n.d.). Ahmed A. Rawwash citation profile.
    https://scholar.google.com/citations?user=TFSCbkAAAAAJ&hl=ar
  4. Medical Hypotheses Journal. (2024). Hypothesis-driven research and scientific innovation.
    DOI: https://doi.org/10.1016/j.mehy.2024.111567
  5. International Research Hypothesis Excellence Award. (n.d.). Award information and eligibility criteria.
    https://researchhypothesis.com/

Radoslaw Kazmierski | Medical Hypotheses | Medical Hypothesis Award

Prof. Dr. Radoslaw Kazmierski | Medical Hypotheses | Medical Hypothesis Award

Professor, University of Zielona Gora, Poland

Prof. Dr. Radoslaw Kazmierski is a distinguished researcher whose expertise lies in neurology, stroke medicine, and cerebrovascular disorders. He has contributed significantly to advancing knowledge in stroke prevention, diagnosis, and treatment through his clinical and translational research. He holds a Ph.D. in medicine with specialization in neurological sciences, which has shaped his academic and research pursuits. Prof. Dr. Radoslaw Kazmierski has actively collaborated on international research projects focusing on stroke risk stratification and cognitive impairment, bringing a global perspective to his work. He has authored 49 documents, accumulating 781 citations with an h-index of 14, demonstrating the academic impact and relevance of his research within the medical community. His publication portfolio includes papers in reputed journals indexed in Scopus and other high-impact platforms, making a substantial contribution to evidence-based medicine. Prof. Dr. Radoslaw Kazmierski has also engaged in leadership roles within academic and clinical research settings, mentoring young researchers and guiding clinical trials. He has been associated with professional memberships in neurology associations and continues to contribute to advancing stroke awareness and patient care standards. His work bridges academia, clinical application, and community health initiatives, making him a valuable contributor to global neurological research.

Profile:Β  Scopus | ORCID

Featured Publications

  1. Short-term outcome after ischemic stroke and 24-h blood pressure variability: association and predictors β€” 2021; cited by multiple studies as a key predictor model.

  2. Serum Paraoxonase/Arylesterase Activity Affects Outcome in Ischemic Stroke Patients β€” 2011; widely cited in studies of redox biomarkers and stroke prognosis.

  3. Zaburzenia mowy i jΔ™zyka u pacjentΓ³w po przebytym udarze mΓ³zgu. Studium epidemiologiczne β€” 2022; epidemiological study of speech and language disorders post-stroke; though newer, it contributes to functional outcomes research.

Aysegul Kilicli | Medical Hypotheses | Best Researcher Award

Assist. Prof. Dr. Aysegul Kilicli | Medical Hypotheses | Best Researcher Award

Assist. Prof. Dr. Aysegul Kilicli Medical Hypotheses | Health sciences faculty at mus alparslan university, Turkey

Dr. AyşegΓΌl KΔ±lΔ±Γ§lΔ± is an Assistant Professor of Nursing at Muş Alparslan University, specializing in women’s health and reproductive care. With a Ph.D. from Gaziantep University, her research focuses on postpartum well-being, maternal mental health, reflexology, breastfeeding, and the use of psychological techniques such as neurolinguistic programming to improve maternal outcomes. She has published numerous high-impact articles in internationally indexed journals (SCI-Expanded, Q2/Q3), contributed to several national projects supported by TÜBΔ°TAK, and presented at more than a dozen international conferences. Her work demonstrates a strong commitment to community-centered research, especially among vulnerable populations such as rural women and seasonal workers. In addition to her research, Dr. KΔ±lΔ±Γ§lΔ± is actively involved in academic teaching, university committees, and continuous professional development through diverse certifications. Her interdisciplinary approach, grounded in both clinical and psychological perspectives, positions her as a promising scholar making significant contributions to women’s health and nursing science.

Professional ProfileΒ 

πŸŽ“ Education Background of Dr. Aysegul Kilicli

Dr. AyşegΓΌl KΔ±lΔ±Γ§lΔ± has built a strong academic foundation in the field of nursing, beginning with her Bachelor’s degree in Nursing from Harran University in 2011. She continued her specialization with a Master’s degree, also from Harran University, in 2016, where she focused her thesis on urinary incontinence among seasonal agricultural worker women. Her academic journey culminated with a Ph.D. in Nursing from Gaziantep University in 2021, where her doctoral research explored the effects of reflexology on postpartum recovery, including pain, fatigue, sleep quality, and lactation. Each stage of her education reflects a deepening commitment to improving women’s health and advancing evidence-based nursing practices.

πŸ’Ό Professional Experience of Dr. Aysegul Kilicli

Dr. AyşegΓΌl KΔ±lΔ±Γ§lΔ± brings over a decade of experience in healthcare and academia, beginning her career as a nurse at ŞanlΔ±urfa Mehmet Akif Δ°nan Training and Research Hospital, where she served from 2011 to 2021, gaining hands-on clinical expertise in patient care and women’s health. In 2021, she transitioned into academia as an Assistant Professor at Muş Alparslan University, Faculty of Health Sciences, in the Department of Women’s Health and Diseases Nursing. Since then, she has been actively engaged in undergraduate nursing education, research, and institutional service. Her dual background in clinical nursing and academic leadership allows her to bridge theory and practice, enriching the learning experiences of her students while contributing meaningfully to community-based health research and scientific development.

πŸ”¬ Research Interests of Dr. Aysegul Kilicli

Dr. AyşegΓΌl KΔ±lΔ±Γ§lı’s research interests lie at the intersection of women’s health, maternal care, mental well-being, and complementary health practices. She focuses extensively on improving health outcomes in the postpartum period, exploring innovative non-pharmacological interventions such as reflexology, neurolinguistic programming (NLP), mindfulness, and progressive muscle relaxation to alleviate pain, fatigue, anxiety, and enhance breastfeeding success. Her work also addresses public health issues in underserved communities, including rural maternal care, urinary incontinence among agricultural workers, and emotional health during pandemics. Driven by a commitment to holistic and evidence-based nursing, Dr. KΔ±lΔ±Γ§lΔ± aims to empower women through preventive healthcare models and psychosocial support strategies that improve both physical and emotional aspects of well-being.

πŸ… Awards and Honors of Dr. Aysegul Kilicli

As of now, Dr. AyşegΓΌl KΔ±lΔ±Γ§lΔ± has not listed any formal awards or honors in her academic curriculum vitae. However, her significant contributions to high-impact research publications, leadership in TÜBΔ°TAK-supported scientific training programs, and active participation in national and international congresses highlight her growing recognition within the academic and healthcare communities. Her steady progress and dedication to women’s health, nursing education, and interdisciplinary research position her as a strong candidate for future academic honors and prestigious research awards.

βœ… Conclusion

Assist. Prof. Dr. AyşegΓΌl KΔ±lΔ±Γ§lΔ± is a highly promising and impactful researcher, particularly in the nursing and women’s health sciences field. Her consistent publication record, applied and community-focused research, and multidisciplinary training make her a strong candidate for recognitionβ€”especially under categories such as Early-Career Researcher, Women in Science, or Applied Health Research.

πŸ“Publications Top Noted

1.Title: Women’s reproductive behaviour and perspectives on fertility, and their modifying factors, in a Turkish province with a high fertility rate

Β  Β  Authors: K. Eroğlu, F. Koruk, Δ°. Koruk, K. Γ‡elik, P. GΓΌner, A. KiliΓ§li

Β  Β  Year: 2021

Β  Β  Citations: 27

2.Title: Stigmatizing attitudes, beliefs, and actions of women towards abortion in rural regions with high fertility

   Authors: Ş. Akbulut, A. Kılıçlı

Β  Β Year: 2022

Β  Β Citations: 8

3.Title: Stress, anxiety, and Postpartum Depression in parents with premature infants in neonatal intensive care unit

Β  Β Authors: A. KΔ±lΔ±Γ§lΔ±, G. SaraΓ§oğlu, A.Γ‡. BΓΌyΓΌkbodur

Β  Β Year: 2023

Β  Β Citations: 5

4.Title: ŞanlΔ±urfa’da kadΔ±n sağlΔ±k Γ§alışanlarΔ±nΔ±n doğurganlΔ±k ΓΆzellikleri ve doğurganlığa bakış aΓ§Δ±larΔ±

Β  Β Authors: F. Koruk, Δ°. Koruk, Γ–. GΓΌner, S. Ayhan, A. KΔ±lΔ±Γ§lΔ±, S. Aytekin, D.U. Altun

Β  Β Year: 2017

Β  Β Citations: 5

5.Title: ŞanlΔ±urfa’da Mevsimlik TarΔ±m İşçisi KadΔ±nlarda Üriner Δ°nkontinans PrevelansΔ±, Tedavi Alma DurumlarΔ± Ve Etkileyen FaktΓΆrler, Hemşirelik Anabilim DalΔ±

Β  Β Authors: A. KΔ±lΔ±Γ§lΔ±

Β  Β Year: 2016

Β  Β Citations: 5

 

 

Esra Seyran | Medical Hypotheses | Best Researcher Award

Assist. Prof. Dr. Esra Seyran | Medical Hypotheses | Best Researcher Award

Assistant Professor at Cumhuriyet University, Turkey

Dr. Esra Seyran is a distinguished molecular biologist and biochemist currently serving as an Assistant Professor at Cumhuriyet University, Turkey. With a Ph.D. in Biochemistry and Molecular Biology from the University of Arkansas, USA, her academic journey spans diverse fields including plant science, protein chemistry, and nanotechnology. She brings extensive international experience, notably as a Scientific Project Officer at the European Commission’s Joint Research Center in Belgium, where she contributed to biosafety and GMO policy development. Dr. Seyran has a strong research portfolio with over 15 publications in high-impact journals, focusing on recombinant protein expression, disease biomarkers, antifungal targets, and nanoparticle-based therapeutic and industrial applications. Her work has earned her prestigious fellowships from institutions such as the United Nations, FAO, and NSF. Notably, she holds a 2023 Turkish patent for a nanomaterial-based COVID-19 treatment formulation. A dedicated educator with two decades of teaching experience in the U.S. and Turkey, Dr. Seyran exemplifies academic excellence, innovation, and interdisciplinary research leadership.

Professional ProfileΒ 

πŸŽ“ Education of Dr. Esra Seyran

Dr. Esra Seyran has pursued a rich and multidisciplinary academic path across prestigious institutions in the USA, Italy, and Turkey. She earned her Ph.D. in Biochemistry and Molecular Biology (2006–2011) from the University of Arkansas, where her dissertation focused on the expression, purification, and redox-dependent disulfide bonding in human Von Willebrand Factor A domains. Prior to that, she completed her M.Sc. in Plant Science (2002–2005) at the same university, with research on temperature interactions in Puccinia striiformis isolates. In 2000–2001, she undertook a post-bachelor’s specialization in Plant-Microbe Interactions at the Instituto Agronomico Mediterraneo di Bari in Italy, supported by an Italian Foreign Ministry Fellowship. Her academic foundation was laid with a B.Sc. in Biochemistry from Ege University, Izmir, Turkey (1993–1999). This diverse and international educational background has empowered her to work at the intersection of molecular biology, plant pathology, and biochemical research.

πŸ’Ό Professional Experience of Dr. Esra Seyran

Dr. Esra Seyran has amassed a diverse and impactful professional career spanning academia, international research institutions, and policy advisory roles. She currently serves as an Assistant Professor at Cumhuriyet University’s Department of Molecular Biology and Genetics in Turkey, where she has been a faculty member since 2014. Prior to her current role, she worked as an Instructor at the same university from 2014 to 2021, teaching advanced courses in biochemistry, toxicology, and genetics. Between 2011 and 2013, Dr. Seyran held the position of Scientific Project Officer at the European Commission’s Joint Research Center (DG-JRC) in Geel, Belgium, where she provided policy advice on biosafety, GMOs, and pesticide regulation, while contributing to capacity-building efforts in alignment with EU standards. Her early career includes roles as a Teaching Assistant in the Department of Chemistry and Biochemistry (2006–2011) and a Research Assistant in Plant Pathology (2002–2005) at the University of Arkansas, where she also engaged in undergraduate instruction across a range of chemistry and biochemistry subjects. This blend of research, teaching, and international policy work reflects Dr. Seyran’s multifaceted expertise and professional versatility.

πŸ”¬ Research Interests of Dr. Esra Seyran

Dr. Esra Seyran’s research interests lie at the intersection of biochemistry, molecular biology, plant pathology, and nanotechnology, with a strong emphasis on translational and interdisciplinary science. Her work focuses on recombinant protein expression and purification, particularly the structural and functional analysis of Von Willebrand Factor domains, which has implications in cardiovascular and hematological disorders. She is also deeply involved in studying biochemical markers for metabolic and macrovascular diseases, such as diabetes. Dr. Seyran explores site-specific protein modifications, such as glycation and acetylation, and their impact on drug-protein interactions. Additionally, she has contributed to the development of nanoparticle-based materials for both therapeutic applications (e.g., COVID-19 treatment formulations) and industrial innovations, including corrosion inhibitors. Her early research in plant-microbe interactions and fungal pathogens also reflects a continued interest in agricultural biotechnology and host-pathogen dynamics. With this broad yet integrated focus, Dr. Seyran aims to bridge fundamental biochemical research with real-world applications in medicine, agriculture, and material science.

πŸ… Awards and Honors of Dr. Esra Seyran

Dr. Esra Seyran has been recognized with numerous prestigious awards and fellowships throughout her academic and professional journey, reflecting her excellence in research, innovation, and international collaboration. In 2016, she was honored with the United Nations Arturo Falaschi Research Fellowship, acknowledging her contributions to molecular biology. She also received the FAO Training Fellowship in 2012 for her work on obsolete pesticide management. During her doctoral studies, she was awarded the Distinguished Doctoral Fellowship by the University of Arkansas Department of Chemistry in 2007, and the same year secured a National Science Foundation Scholarship for advanced training in microbial genetics at the Craig Venter Institute. Earlier accolades include the Asia Rice Foundation Research Award in 2006, and the Graduate School Travel Award from the University of Arkansas in 2004. Dr. Seyran also benefited from the Italian Foreign Ministry Cultural Exchange Scholarship (2000–2001), which supported her studies in plant-microbe interactions in Italy. These honors highlight her outstanding academic potential, international impact, and dedication to scientific advancement.

🏁 Conclusion

Dr. Esra Seyran presents a highly competitive and well-rounded profile suitable for the Best Researcher Award. Her work bridges cutting-edge biochemistry, biomedical innovation, agricultural science, and public policy, making her a rare multidisciplinary contributor. Her global research footprint, commitment to teaching, technical competencies, and novel contributions (e.g., patent) strongly support her eligibility and worthiness for recognition.

πŸ“š Publications Top Noted

  1. Title: Aggressiveness of Puccinia striiformis f. sp. tritici isolates in the south-central United States
    Authors: EA Milus, E Seyran, R McNew
    Year: 2006
    Cited by: 190
  2. Title: New breeding techniques and their possible regulation
    Authors: E Seyran, W Craig
    Year: 2018
    Cited by: 23
  3. Title: Examination of the rice blast pathogen population diversity in Arkansas, USA – Stable or unstable?
    Authors: JC Correll, EJ Boza, E Seyran, RD Cartwright, Y Jia, FN Lee
    Year: 2009
    Cited by: 20
  4. Title: A preliminary characterization of the rice blast fungus on β€˜Banks’ rice
    Authors: FN Lee, RD Cartwright, Y Jia, JC Correll, KAK Moldenhauer, JW Gibbons, V Boyett, E Zhou, E Boza, E Seyran
    Year: 2004
    Cited by: 20
  5. Title: New Races of Puccinia striiformis f. sp. tritici More Aggressive Than Older Races
    Authors: ESE Milus
    Year: 2005
    Cited by: 9
  6. Title: Aggressiveness of Puccinia striiformis f. sp. tritici
    Authors: EA Milus, E Seyran, R McNew
    Year: 2006
    Cited by: 3
  7. Title: Fungal homoserine transacetylase: a potential antifungal target
    Authors: E Seyran
    Year: 2021
    Cited by: 2
  8. Title: Isolate by temperature interaction for aggressiveness among isolates of Puccinia striiformis f. sp. tritici
    Authors: E Seyran, EA Milus
    Year: 2004
    Cited by: 2
  9. Title: The effects of aspirin acetylation of human serum albumin on its interactions with methotrexate
    Authors: Esra Seyran, Serap Cetinkaya
    Year: 2025
    Cited by: 1
  10. Title: Nanoparticle-Based Corrosion Inhibitors
    Authors: E Seyran, G TΓΌzΓΌn, S Γ‡etinkaya, B TΓΌzΓΌn
    Year: 2024
    Cited by: 1

Shahbaz Ul Haq | Medical Hypotheses | Best Researcher Award

Shahbaz Ul Haq | Medical Hypotheses | Best Researcher Award

Postdoctoral at Shantou university medical college, China

Dr. Shahbaz Ul Haq is an accomplished veterinary scientist and postdoctoral researcher at Shantou University Medical College, China. With a Ph.D. in Basic Veterinary Medicine from the Chinese Academy of Agricultural Sciences, his work focuses on antimicrobial resistance (AMR) and zoonotic infections. His groundbreaking research investigates the synergistic potential of artemisinin derivatives to boost antibiotic efficacy against multidrug-resistant E. coli. Dr. Haq has held technical leadership roles in Pakistan’s veterinary industry, implementing evidence-based treatment protocols and exploring alternatives to antibiotics in livestock. He has authored impactful publications in top-tier journals like Frontiers in Veterinary Science and European Journal of Pharmacology. Dr. Haq has also been honored as a β€œShantou High-Level Talent” and received the β€œBest Researcher Award” by ScienceFather. With international training, collaborative projects, and a strong publication record, he is a recognized authority in veterinary microbiology and One Health.

Publication Profile

Google Scholar

Education

Dr. Shahbaz Ul Haq holds a Ph.D. in Basic Veterinary Medicine from the Chinese Academy of Agricultural Sciences (2018–2022), where he focused on enhancing antibiotic activity through artemisinin derivatives. His coursework included advanced studies in immunology, microbiology, veterinary epidemiology, and Chinese culture. He earned his M.Phil. in Clinical Medicine and Surgery from the University of Agriculture, Faisalabad (2016–2018), conducting a comparative study on udder edema in dairy goats. Earlier, he completed a Doctor of Veterinary Medicine (DVM) degree from the same university (2010–2015), with a strong foundation in parasitology, virology, public health, and pathology. His academic path reflects a consistent emphasis on veterinary health, disease management, and clinical research. He also undertook several international workshops and advanced trainings in veterinary diagnostics, AMR surveillance, and zoonotic disease control across China, Morocco, Italy, and Pakistan.

Experience

Dr. Haq currently serves as a Postdoctoral Researcher at Shantou University Medical College, China, where his research addresses multidrug-resistant bacteria and antibiotic resistance. Previously, he worked as a Technical Manager at Polaris Life Sciences in Pakistan (2022–2023), focusing on reducing antibiotic residues in food through alternatives like probiotics. As Technical Executive at Forward Solutions (2015–2016), he explored mineral supplementation and metabolic disorders in livestock. He also interned at Sarbuland Dairy Farm, learning dairy management protocols. Dr. Haq has actively contributed to project proposals under the China Postdoctoral Science Foundation and National Natural Science Fund of China. He has participated as a speaker in numerous international conferences and workshops on animal health, veterinary biotechnology, and traditional medicine. With strong field and laboratory experience, he bridges academic research and real-world veterinary challenges.

Awards and Honors

Dr. Shahbaz Ul Haq has received notable national and international recognition for his research contributions. He was honored as a β€œShantou High-Level Talent” in China, a prestigious recognition of exceptional scientific contributions. In 2025, he received the β€œBest Researcher Award” in Traditional Medicine from ScienceFather. He also serves as an Editorial Board Member for the New Scientists Awards, under Scifax Company Group. His academic journey was supported by competitive scholarships, including the Chinese Government Scholarship (CGS) for his Ph.D., and the Punjab Educational Endowment Fund (PEEF) for his M.Phil. Dr. Haq has presented at numerous international forums, including conferences in Italy, Morocco, China, and Pakistan. His participation in postdoctoral research forums and his leadership in AMR-focused projects further solidify his standing as a rising global voice in veterinary science and One Health research.

Research Focus

Dr. Haq’s research is centered on antimicrobial resistance (AMR), zoonotic pathogens, and veterinary pharmacology. His Ph.D. research demonstrated the synergistic effect of artemisinin derivatives in enhancing Ξ²-lactam and fluoroquinolone efficacy against multidrug-resistant E. coli, offering new hope in the fight against AMR. At Shantou University, his postdoctoral work continues to explore novel combinations of natural compounds and conventional antibiotics. Dr. Haq is also active in genetic epidemiology, studying mitochondrial gene variation in zoonotic parasites like Taenia multiceps, Clonorchis sinensis, and Echinococcus granulosus. His work integrates bioinformatics, microbial genomics, drug resistance profiling, and public health risk assessment. In applied veterinary settings, he has led research into probiotic alternatives, parasite control, and clinical treatment protocols to reduce antibiotic residues in livestock products. His interdisciplinary approach spans One Health, molecular microbiology, and pharmacogenomics.

Publication Top Notes

Revealing novelΒ cytbΒ andΒ nad5 genes-based population diversity and benzimidazole resistance inΒ Echinococcus granulosusΒ of bovine origin

Anticoccidial Activity of Qinghao Powder AgainstΒ Eimeria tenellaΒ in Broiler Chickens

Toxicological evaluation of the ultrasonic extract fromΒ Dichroae radixΒ in mice and wistar rats

Regulation and analysis of the diversity of intestinal microbiota in SD rats by Danggui Buxue Tang (DBT) fermented withΒ Bacillus subtilis

Drug resistance modulation of dairy MRSA through Berberine. Artesunate and Quercetin in Combination with Ξ²-Lactams

Subclinical Mastitis in Small-Holder Dairy Herds of Gansu Province, Northwest China: Prevalence, Bacterial Pathogens, Antimicrobial Susceptibility, and Risk Factor Analysis

Comparison of photosensitized tissue bonding and vet glue in closure of incisional wounds.

 

Angela Caiado | Medical Hypotheses | Best Researcher Award

Angela Caiado | Medical Hypotheses | Best Researcher Award

Dr Angela Caiado, Universidade de Sao Paulo, Brazil

Dr. Angela Caiado is a distinguished medical professional and academic, currently pursuing her PhD in Radiology at the University of SΓ£o Paulo (USP), Brazil. With over two decades of expertise, she specializes in abdominal and pelvic imaging with significant contributions to colorectal cancer diagnosis, inflammatory bowel disease, and liver transplantation imaging. She holds an MD from USP and is also completing an MBA in Business Management from FGV, reflecting her commitment to both clinical excellence and leadership. As Head of Radiology at Grupo Fleury and a former instructor at Hospital das ClΓ­nicas – USP, Dr. Caiado has mentored many budding radiologists. Her research is internationally recognized, with presentations at RSNA, ESGAR, and PANCCO. She has also collaborated globally, including with Harvard T.H. Chan School of Public Health. Her deep dedication to translational imaging science and patient care integration makes her a highly deserving candidate for the Best Researcher Award.

Publication Profile

Scopus

Education

Dr. Caiado earned her Doctor of Medicine (MD) degree from the University of SΓ£o Paulo (USP), Brazil, where she also completed her residency in Radiology and Diagnostic Imaging (2001–2004) and specialized training in Abdominal Imaging (2004–2005). Currently, she is pursuing a PhD in Radiology at USP, with her thesis focusing on CT colonography with mannitol preparation for detecting synchronous tumors in colorectal cancer, under the guidance of Prof. Carlos Buchpiguel. Complementing her medical background, she is undertaking an MBA in Business Management at FundaΓ§Γ£o GetΓΊlio Vargas (FGV), Brazil, to enhance her healthcare leadership skills. Her strong academic trajectory showcases a rare blend of clinical depth and managerial vision, enabling her to bridge radiology science and healthcare operations effectively. This comprehensive education foundation has empowered her to drive impactful research and assume senior clinical leadership roles while actively contributing to academic advancement in radiology.

Experience

Dr. Angela Caiado has held pivotal roles in clinical radiology for over 20 years. Since 2004, she has been the Head of Radiology and Diagnostic Imaging at Grupo Fleury, one of Brazil’s most prestigious medical institutions, where she also serves as a Senior Radiologist specializing in abdominal and pelvic imaging. From 2004 to 2017, she served as an Assistant Radiologist and residency instructor at Hospital das ClΓ­nicas – USP. Her academic engagements include an international teaching role at Harvard T.H. Chan School of Public Health as an Assistant Professor in the PPCR Program. Dr. Caiado also broadened her expertise through an observer fellowship at The Royal Marsden Hospital in London in 2017. Her career exemplifies a seamless integration of leadership, education, and clinical service, underscoring her versatility and dedication to advancing medical imaging, patient care, and interdisciplinary training.

Awards and Honors

Dr. Angela Caiado has earned multiple awards and accolades for her contributions to radiology and clinical research. Her presentations have been consistently recognized at the Jornada Paulista de Radiologia, where she received several awards for her excellence in abdominal and pelvic imaging studies. She has been a regular invited speaker at major radiological and gastrointestinal conferences such as RSNA, ESGAR, FICARE, and PANCCO, reflecting peer recognition of her work’s quality and clinical impact. As a global contributor, her teaching role in the Harvard PPCR program further highlights her reputation in academic circles. She has also contributed chapters to landmark radiology and gastrointestinal textbooks published by Elsevier, Manole, Atheneu, and Springer. These accolades demonstrate her thought leadership and dedication to enhancing medical knowledge across radiology disciplines.

Research Focus

Dr. Angela Caiado’s research is centered on advanced imaging in gastrointestinal and hepatobiliary diseases, particularly colorectal cancer, inflammatory bowel disease (IBD), and liver transplantation. Her PhD research focuses on using CT colonography with mannitol preparation to improve the detection of synchronous tumors in obstructive colorectal cancer. She is also engaged in multiparametric MRI studies and elastography for liver and spleen evaluations, with promising applications in myelofibrosis and chronic liver conditions. Dr. Caiado’s work aims to refine diagnostic accuracy, improve pre-surgical assessments, and contribute to non-invasive disease monitoring. Her approach often emphasizes radiological-surgical integration, fostering improved multidisciplinary collaboration. Her translational research consistently bridges clinical radiology and patient-centered outcomes, reinforcing her standing as a trailblazer in abdominal imaging and radiological innovation.

Publication Top Notes

Marzieh Kaboudi | Medical Hypotheses | Best Researcher Award

Marzieh Kaboudi | Medical Hypotheses | Best Researcher Award

Assist. Prof. Dr Marzieh Kaboudi, kums, Iran

Assist. Prof. Dr. Marzieh Kaboudi is a distinguished academician and researcher in reproductive health and midwifery with over three decades of experience in teaching, administration, and scholarly contributions. She earned her Ph.D. in Reproductive Health from Shahid Beheshti University and has held several leadership roles at the Kermanshah University of Medical Sciences. Known for her pioneering work in maternal and women’s health, she has served as Head of the Reproductive Health Department, Dean of the Nursing and Midwifery School, and an active member of research councils. Her impactful research spans maternal care, women’s reproductive behavior, and health education. She is also a respected reviewer and scientific chair in national congresses. Her ongoing dedication to advancing reproductive health science through research, teaching, and policy advocacy marks her as a highly deserving candidate for the Best Researcher Award.

Publication Profile

Google Scholar

Education

Dr. Marzieh Kaboudi’s academic journey began with a B.A. in Midwifery from Kermanshah University of Medical Sciences (1987–1991) πŸŽ“. She pursued her M.A. in Midwifery Education at Ahvaz University of Medical Sciences (1994–1997) πŸ“˜, and later earned a Ph.D. in Reproductive Health from Shahid Beheshti University of Medical Sciences, Tehran (2008–2013) πŸŽ“. Her educational path reflects a deep commitment to advancing women’s health and reproductive education. Her postgraduate focus on reproductive health laid the foundation for her expertise in promoting maternal dignity, pregnancy outcomes, and health behavior change. These qualifications have equipped her with the theoretical knowledge and research skills essential for effective teaching, leadership, and impactful scientific inquiry. Her academic background is complemented by specialized certifications in research methods and sexual health, enhancing her ability to lead innovative studies and mentor future healthcare professionals.

Experience

Dr. Kaboudi’s career showcases a robust record of academic and administrative excellence. She served as Head of the Reproductive Health Department at the School of Nursing and Midwifery, Kermanshah University of Medical Sciences (2017–2022) πŸ₯. Previously, she was Dean of the Nursing and Midwifery School (2014–2017), and Deputy Head of School (2008–2014) πŸ“‹. Earlier roles include Head of Midwifery Department (1999–2005) and Boss of the Educational Development Office (2006–2008) 🧾. She has been an influential member of the Research Council (2001–2008) and continues to serve as a referee for the university’s scientific journal πŸ“°. Her leadership contributions span educational policy-making, research mentorship, and conference organization. Dr. Kaboudi’s experience reflects an unwavering dedication to elevating academic standards, fostering research, and improving reproductive health education. Her diverse roles demonstrate her ability to lead multidisciplinary teams and influence policy and education in healthcare.

Honors and Awards

Dr. Kaboudi’s commitment to academic excellence has earned her several prestigious accolades. She received the Outstanding Professor Prize for three consecutive years at Kermanshah University of Medical Sciences, honoring her excellence in teaching and research πŸ†. She also held the Scientific Chair at national congresses such as the 2007 National Congress on Research in Education and the 2001 National Congress on Blood Health 🧠. Her academic contributions are further recognized by her ongoing role as a peer reviewer for the university’s scientific journal since 2002 πŸ“. In addition to these honors, she has obtained specialty certifications in research methods and sexual health education, including advanced training on child sexual health and the assessment of sexual dysfunctions πŸ“œ. These achievements reflect her commitment to lifelong learning, innovative pedagogy, and reproductive health advocacy. Her awards and recognitions validate her role as a transformative leader in reproductive health research.

Research Focus

Dr. Marzieh Kaboudi’s research centers on maternal and reproductive health, health behavior change, and women’s health education. Her work investigates key issues such as neural tube defects, preeclampsia, obesity in middle-aged women, reproductive intentions, and maternal dignity 🧬. She utilizes methodologies grounded in behavioral science, including the Theory of Planned Behavior, to examine interventions that enhance reproductive outcomes πŸ“Š. Her contributions extend to health promotion, reproductive decision-making, and the development of validated tools for patient satisfaction measurement. She has also explored sexual and metabolic health, menopause knowledge, and reproductive practices among Iranian women. Through her national and international presentations, she emphasizes ethical standards, health equity, and psychosocial well-being πŸ’¬. Her research bridges the gap between clinical knowledge and public health policy, ultimately empowering women with better reproductive choices and outcomes. With an eye toward innovation and advocacy, Dr. Kaboudi’s work continues to shape the future of reproductive healthcare.

Publication Top Notes

A genome-wide association study to identify candidate genes for erectile dysfunction

A Comparison of Quality of Life, Anxiety and Depression in Children with Cancer and Healthy Children, Kermanshah-Iran

The effect of acceptance and commitment therapy on the mental health of women patients with type II diabetes

The decision-making process of childbearing: a qualitative study

The Effect of Resilience Training on the Condition of Style of Coping and Parental Stress in Mothers of Children with Leukemia

A Study of Health Literacy Components and their Relationships with Health-Promoting Behaviors in Students at Kermanshah University of Medical Sciences

The relationship between emotional intelligence and mental health with social anxiety in blind and deaf children

Investigation of gene expression and genetic simultaneous control associated with erectile dysfunction and diabetes

Daniel Rudofossi | Medical Hypotheses | Best Researcher Award

Daniel Rudofossi | Medical Hypotheses | Best Researcher Award

Dr Daniel Rudofossi, Expert Witness, United States

Dr. Daniel Rudofossi is a distinguished psychologist, researcher, and former NYPD uniform psychologist specializing in trauma, existential analysis, and police/public safety psychology. Holding a Psy.D. in Existential Analysis and a Ph.D. in Psychology from NYU (Summa Cum Laude), he integrates cognitive-behavioral, psychodynamic, and logotherapy approaches in his practice. A Certified Fellow at the Albert Ellis Institute and the Viktor Frankl Institute, Dr. Rudofossi has developed the Eco-Ethological Existential Analysis model for complex PTSD in law enforcement. As Chief Psychologist of the NY & NJ Detective Crime Clinic and an Honorary Police Surgeon, he has significantly contributed to officer wellness. His research and clinical expertise have earned him national recognition, multiple citations for bravery, and invitations to prestigious symposiums. With extensive publications and numerous invited lectures, Dr. Rudofossi continues to shape the field of trauma psychology, ensuring mental resilience for law enforcement professionals. πŸš”πŸ“–πŸ’‘

Publication Profile

Scopus

Education

Dr. Daniel Rudofossi is a distinguished psychologist specializing in existential psychology, trauma, and law enforcement psychology. He earned his Psy.D. in Existential Psychology in 2007 and holds a Ph.D. in Psychology from New York University (Summa Cum Laude, 1997) πŸŽ“πŸ†. His academic journey includes an M.A. in Psychology (4.0 GPA, 1993) and an M.A. in Evolutionary Behavioral Science (3.8 GPA, 1987) from NYU, along with a B.A. in History & Psychology from CUNY (3.76 GPA, 1985). A Certified Fellow in Rational Emotive Behavior Therapy (Albert Ellis Institute, 1996) and certified in Logotherapy (Viktor Frankl Institute), he also holds a Psychoanalytic Psychotherapy Certification (NYPI & Society). Dr. Rudofossi is a Board-Certified Expert in Traumatic Stress (AAETS, 1997) and a graduate of the NYPD Police Academy (1987) πŸš”πŸ”¬πŸ“š. His expertise bridges psychology and law enforcement, making profound contributions to officer wellness and trauma-informed therapeutic approaches.

Experience

Dr. Daniel Rudofossi is a distinguished psychologist with a remarkable career in law enforcement and academia. He served as a Retired Uniform Psychologist in the NYPD Medical Division (1996-2000) and later became the Director of the NYPD Membership Assistance Program, now known as PAPA. As the Chief Psychologist for the NY & NJ Detective Crime Clinic πŸ•΅οΈβ€β™‚οΈπŸ§ , he provided critical mental health support to officers. Honored as a Police Surgeon by the NY State Police and Amtrak FOP Lodge NY, he has also been an Adjunct Associate Professor at New York University since 2001 πŸŽ“ and an Adjunct Professor at John Jay College of Criminal Justice. A consultant for NYPD Psychological Services πŸ›οΈ, he also serves on Saybrook University’s Clinical Psychology Program board. Dr. Rudofossi was a US DOJ DEA EAP Administrative Clinician (2008-2010) and is a respected lecturer and researcher specializing in trauma, PTSD, and law enforcement psychology.

Awards & Honors

Dr. Daniel Rudofossi is a distinguished expert in police trauma and forensic psychology, with a remarkable career blending law enforcement and mental health. A former NYPD officer, he earned six Citations for Bravery in the Line of Duty πŸš”πŸ”₯ and served as an Honorary Police Surgeon for the NYPD and the NY State Police Investigators Union. A Certified Fellow of the Albert Ellis Institute πŸ…, he is also a Diplomate and Board-Certified Expert in Traumatic Stress (AAETS). Dr. Rudofossi has been an invited speaker at prestigious events, including the APA, the Viktor Frankl Institute, and Police Training Symposiums 🎀. His expertise has been nationally televised πŸ“Ί, focusing on police trauma and suicide prevention. Recognized by the California Commission on Peace Officer Standards & Training (2007), he has contributed to the DSM Treatment & Statistical Manual One πŸ“–πŸ”¬, shaping mental health approaches for first responders and trauma survivors.

Research Focus

Dr. Rudofossi specializes in trauma psychology, existential analysis, and police/public safety mental health. His Eco-Ethological Existential Analysis (EEEA) model provides an integrative approach to complex PTSD in law enforcement officers. His research explores coping mechanisms for police stress, disenfranchised loss, and suicide prevention among first responders. He has collaborated with top institutions like APA, Viktor Frankl Institute, and Albert Ellis Institute, contributing to theories on cognitive-behavioral therapy, logotherapy, and psychodynamic approaches in high-risk professions. His work aims to enhance resilience, improve officer wellness programs, and refine trauma intervention techniques in law enforcement.

Publication Top Notes

  • Conference on Trauma & Loss in Police & Military Combat Veterans (2006)

  • Eco-Ethological Existential Analysis of Police PTSD – APA Symposium (2006)

  • Reinfranchising Loss in Police Complex Trauma – APA Symposium (2007)

  • Police Suicide Prevention & Intervention – CA POST Training (2007)

  • International Journal of Logotherapy – Trauma in Law Enforcement (2007)

  • Training Module on Police Suicide Prevention – Viktor Frankl Institute (2007)

  • Lecture at Albert Ellis Institute – Integrative Approach to PTSD (2007)

  • Nationally Televised Expert on Police Suicide Prevention – CBS Primetime (2019)

 

Sangil Park | Medical Hypotheses | Best Researcher Award

Sangil Park | Medical Hypotheses | Best Researcher Award

Prof Sangil Park, Department of Neurology, Uijeongbu Eulji Medical Center, South Korea

Prof. Sangil Park is a dedicated neurologist and clinical researcher with expertise in stroke, neurocritical care, and neuro-intervention. πŸ§ πŸ’‰ He serves as a Clinical Assistant Professor at Uijeongbu Eulji Medical Center and has completed fellowships in radiology, neurology, and critical care. πŸŒŸπŸ“š Holding a Ph.D. from Kyung Hee University, Dr. Park is certified in neurology, acute stroke care, and critical care medicine. πŸŽ“πŸ… His research includes innovative treatments for vascular diseases and digital health applications. πŸ©ΊπŸ“Š An active member of multiple neurological societies, he has published extensively and presented at international conferences. πŸŒπŸ“ Dr. Park’s work reflects a passion for advancing neurological care. ✨

Publication Profile

Orcid

EducationΒ 

Prof. Sangil Park boasts an impressive educational journey and certifications in medicine and engineering. He earned his Ph.D. in Medicine from Kyung Hee University (2023) πŸ§‘β€πŸŽ“, where he also completed his M.D. (2014) 🩺. Prior to this, he obtained a B.D. in Electrical Engineering and Computer Science from Hanyang University (2009) πŸ’». Prof. Park holds the Korean Board of Neurology (2022) 🧠, the Certification of TPI from The Korean Orthopedic Pain Society (2022) πŸ₯, and the Subspecialty Board of Critical Care Medicine (2024) πŸ«€. Additionally, he is a certified Acute Stroke Neurologist (2024) ⚑, blending expertise in neurology and technology.

Career BackgroundΒ 

Prof. Sangil Park is a dedicated neurologist with extensive clinical experience and academic achievements. Since March 2024, he has been serving as a Clinical Assistant Professor at Uijeongbu Eulji Medical Center πŸ₯. He previously held fellowships in Radiology at Asan Medical Center (2023-2024) and in Neurology and Critical Care Medicine at Kyung Hee University Medical Center (2022-2023) πŸ”¬πŸ§ . Prof. Park completed his Neurology residency at Kyung Hee University Hospital at Gangdong (2018-2022) and internship at Kyung Hee University Medical Center (2017-2018) πŸ‘¨β€βš•οΈ. His military service included working as a public health doctor in Changnyeong-gun (2014-2017) πŸš‘πŸ‡°πŸ‡·.

Experience

Prof. Sangil Park’s groundbreaking work focuses on neurological and cerebrovascular health through advanced clinical research. 🌟🧠 He led a post-marketing safety study on Emgality (Galcanezumab) for migraine prophylaxis in adults in Korea (SIT, PMS2020-014-005) πŸ’Š, and explored neuroprotection with neu2000 in acute ischemic stroke patients through a phase-III randomized trial (2021-10-090). πŸ”¬ In another study, he evaluated atrial fibrillation’s prevalence and impact in elderly patients with cryptogenic stroke and patent foramen ovale (2021-04-034). πŸ’“ His contributions extend to assessing Choline Alfoscerate’s safety and efficacy in mild cognitive impairment with cerebrovascular disease in a phase-IV trial (2021-07-094). πŸ§ͺπŸ“ˆ

PresentationΒ 

Prof. Sangil Park has contributed extensively to stroke and neurovascular research. Key presentations include delayed post-hypoxic leukoencephalopathy after ischemic stroke at the 15th ESMINT Congress (2023) 🧠, and styloidogenic jugular venous compression syndrome at the Asia Pacific Stroke Conference (2022) 🩺. His studies on carotid artery restenosis after stenting at the 14th World Stroke Congress (2022) and predictors of in-stent restenosis at the KSIN Summer Intensive Course (2024) provide valuable insights πŸ“Š. Prof. Park has also explored COVID-19 vaccination’s link to ischemic stroke 🦠 and innovative treatments for cavernous sinus dural AVFs (2023) 🩸, advancing neurovascular care worldwide. 🌍

Professional RecognitionΒ 

Prof. Sangil Park is a dedicated neurologist with memberships in multiple prestigious societies, reflecting his commitment to advancing the field. πŸŒπŸ“š His consistent focus on cutting-edge research has significantly contributed to the understanding and treatment of neurological conditions. πŸ§ πŸ”¬ Specializing in stroke and neurocritical care, Prof. Park has made impactful strides in improving patient outcomes through collaborative research efforts. πŸ€πŸ’‘ His work bridges innovation and clinical application, ensuring better care for patients worldwide. πŸ₯🌟 A true leader in neurology, he continues to inspire progress in the field, shaping the future of neuroscience and neurocritical care. πŸš€βœ¨

Research Focus

Prof. Sangil Park’s research primarily focuses on neurovascular diseases, endovascular treatments, and innovative diagnostic approaches. His studies include targeted embolization for cavernous sinus dural arteriovenous fistulas πŸ’‰πŸ§ , advanced imaging markers like the HARM sign for transient ischemic attacks 🩻🚨, and real-world applications of digital health technologies for chronic conditions like hypertension and diabetes πŸ“±πŸ’Š. His work extends to rare conditions, such as medullary hemangioblastomas and cerebral vasculitis 🩸🧬, reflecting a broad interest in improving patient outcomes through multidisciplinary approaches. His contributions to neurosonology and embolization emphasize precision medicine in neurology and radiology. πŸŒŸπŸ“š

Publication Top Notes

Endovascular Treatment With Targeted Embolization of Cavernous Sinus Dural Arteriovenous Fistulas: A Single-Center Study